Last updated on November 2017

Diabetic Gastroparesis

Brief description of study

Diabetic Gastroparesis

Detailed Study Description

A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM -131 administered to patients with diabetic gastroparesis

Clinical Study Identifier: TX2717


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Wake Research Associates

Wake Research Associates
Raleigh, NC USA
  Connect »

Robert Hardi, MD, AGAF, CPI

MGG Group Co., Inc., Chevy Chase Clinical Research
Chevy Chase, MD USA
  Connect »